In this study we found that macrophage metalloelastase, MMP-12 cleaves, in vitro, apolipoprotein(a) (apo ( ) who by combining chemical and immunochemical techniques provided evidence that urinary apo(a) was represented by fragments derived from its N-terminal region. When, following purification, these urinary fragments were injected intravenously into mice, they were excreted in the urine without an apparent change in size. The same authors also reported the presence in the plasma of apo(a) fragments unattached to apoB100. Upon their intravenous injection into mice, these fragments were rapidly excreted in the urine as smaller sized components (3). Taken together, the results were interpreted to indicate that the apo(a) fragments in human plasma are derived from Lp(a)/apo(a) and are in turn the source of the apo(a) fragments in the urine. Unanswered in those studies was the underlying cause of the apo(a) fragmentation as well as the site or sites for its occurrence. We reported previously that limited in vitro proteolysis of apo(a), by either pancreatic or leukocyte elastase, is attended by the cleavage at the Ile 3520 -Leu 3521 bond located in the linker domain between kringles IV-4 and IV-5 (4, 5). This cleavage generates two main fragments, one representing the N-terminal domain, F1, and the other the C-terminal domain, F2. When these two fragments were separately injected intravenously into mice, F1 but not F2 was rapidly excreted in the urine (4). This observation prompted us to examine whether the cleavage site on apo(a) was limited to serine proteases such as pancreatic and leukocyte or neutrophil elastase (NE) or could also apply to other inflammatory enzymes. Among them we considered matrix matalloproteinases (MMPs), which are metallo-dependent enzymes involved in the homeostasis of the extracellular matrix and also shown to play an important role in the atherosclerotic process (6 -13). In this work, we directed our attention to macrophage metalloelastase, also referred to as MMP-12, which was first identified as an elastolytic metalloproteinase secreted by inflammatory macrophages (14) and structurally defined (15,16). This enzyme has a broad substrate specificity for matrix macromolecules such as fibronectin, laminin, vitronectin, and proteoglycans (17). In the current study, we now show that MMP-12 cleaves apo(a) in vitro and also provide evidence that, in the mouse strain used, it is involved in the generation of F1 in vivo.
EXPERIMENTAL PROCEDURESReagents-Human leukocyte elastase (EC 3.4.21.37) was purchased from Sigma. Antiserum to purified preparations of apo(a), Lp(a), and LDL were raised in the rabbit and affinity purified as described previously (18). Anti-Lp(a) were shown to be devoid of immunoreactivity to LDL and plasminogen; anti-LDL was unreactive to apo(a).Studies in Mice-Mice deficient in NE (NE Ϫ/Ϫ ) or MMP-12 (MMP-12 Ϫ/Ϫ ) in a pure 129/Svj background were generated by targeted disruption of either the NE or MMP-12 gene in RW4 embryonic stem cells as described previously (19,20). Al...